Further, AEBP1 expression was elevated in HSCs concomitant with NAFLD progression [10], indicating that increased, not decreased, expression occurs with myofibroblastic activation. This evidence concerns the gene AEBP1 and metabolic dysfunction-associated steatotic liver disease.